Additionally, miR-92a was also predicted to target GATA-binding factor 6 (GATA6), a gene related to androgen production, possibly suggesting a relationship between insulin and androgenic signaling pathways in PCOS patients [50]. The gene discussed is GATA6; the disease is polycystic ovary syndrome.